← Back to Search

Habit Reversal Training for Tics

N/A
Waitlist Available
Led By Joseph F McGuire, PhD
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 1 week after completion of hrt
Awards & highlights
No Placebo-Only Group

Summary

This trial tests how well children with Tourette syndrome can learn and remember to stop their tics using a special task. It aims to understand and improve behavioral treatments for controlling tics.

Eligible Conditions
  • Tourette Syndrome
  • Habit Reversal Training
  • Tics

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 1 week after completion of hrt
This trial's timeline: 3 weeks for screening, Varies for treatment, and within 1 week after completion of hrt for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Tic severity as assessed by the Hopkins Motor and Vocal Tic Scale (HM/VTS)
Secondary study objectives
Tic severity as assessed by the Yale Global Tic Severity Scale-Revised (YGTSS)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Habit Reversal TrainingExperimental Treatment1 Intervention
Habit Reversal Training (HRT) is a multi-component evidence-based treatment for tics. It will be delivered over 4 two-hour sessions in an intensive format.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Habit Reversal Training
2020
N/A
~80

Find a Location

Who is running the clinical trial?

Johns Hopkins UniversityLead Sponsor
2,328 Previous Clinical Trials
14,874,605 Total Patients Enrolled
4 Trials studying Tics
169 Patients Enrolled for Tics
Joseph F McGuire, PhDPrincipal InvestigatorJohns Hopkins University
2 Previous Clinical Trials
160 Total Patients Enrolled
2 Trials studying Tics
160 Patients Enrolled for Tics
~3 spots leftby Dec 2025